Free Trial

Legal & General Group Plc Sells 20,332 Shares of Markel Group Inc. (NYSE:MKL)

Markel Group logo with Multi-Sector Conglomerates background
Remove Ads

Legal & General Group Plc lowered its position in Markel Group Inc. (NYSE:MKL - Free Report) by 20.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,022 shares of the insurance provider's stock after selling 20,332 shares during the quarter. Legal & General Group Plc owned about 0.61% of Markel Group worth $136,410,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in MKL. Private Trust Co. NA boosted its stake in Markel Group by 23.1% during the 4th quarter. Private Trust Co. NA now owns 32 shares of the insurance provider's stock valued at $55,000 after purchasing an additional 6 shares in the last quarter. Wellington Shields & Co. LLC lifted its holdings in shares of Markel Group by 4.3% in the fourth quarter. Wellington Shields & Co. LLC now owns 145 shares of the insurance provider's stock valued at $250,000 after purchasing an additional 6 shares in the last quarter. Gilbert & Cook Inc. boosted its position in shares of Markel Group by 1.7% in the fourth quarter. Gilbert & Cook Inc. now owns 428 shares of the insurance provider's stock worth $739,000 after buying an additional 7 shares during the period. Greenleaf Trust grew its holdings in shares of Markel Group by 3.4% during the 4th quarter. Greenleaf Trust now owns 213 shares of the insurance provider's stock worth $368,000 after purchasing an additional 7 shares in the last quarter. Finally, Concurrent Investment Advisors LLC raised its stake in shares of Markel Group by 1.5% in the fourth quarter. Concurrent Investment Advisors LLC now owns 469 shares of the insurance provider's stock valued at $810,000 after purchasing an additional 7 shares in the last quarter. Institutional investors own 77.12% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of research firms have weighed in on MKL. Royal Bank of Canada lifted their price target on shares of Markel Group from $1,750.00 to $2,025.00 and gave the stock a "sector perform" rating in a research note on Friday, February 7th. StockNews.com lowered shares of Markel Group from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. Based on data from MarketBeat.com, Markel Group currently has an average rating of "Hold" and an average price target of $1,702.20.

Get Our Latest Research Report on MKL

Markel Group Price Performance

Shares of NYSE MKL traded down $6.46 during midday trading on Tuesday, reaching $1,781.80. 25,337 shares of the company traded hands, compared to its average volume of 47,933. The stock's 50-day simple moving average is $1,854.48 and its 200-day simple moving average is $1,748.25. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.60 and a current ratio of 0.60. Markel Group Inc. has a 12 month low of $1,417.65 and a 12 month high of $2,063.68. The firm has a market cap of $22.65 billion, a PE ratio of 8.95 and a beta of 0.70.

Markel Group (NYSE:MKL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $20.51 earnings per share for the quarter, missing analysts' consensus estimates of $20.66 by ($0.15). Markel Group had a net margin of 16.34% and a return on equity of 7.55%. As a group, equities analysts anticipate that Markel Group Inc. will post 96.25 earnings per share for the current fiscal year.

Insider Activity

In other Markel Group news, Director Steven A. Markel sold 800 shares of the firm's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $1,856.80, for a total value of $1,485,440.00. Following the transaction, the director now directly owns 64,868 shares of the company's stock, valued at approximately $120,446,902.40. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Thomas Sinnickson Gayner bought 100 shares of the company's stock in a transaction on Friday, February 7th. The shares were acquired at an average price of $2,008.01 per share, with a total value of $200,801.00. Following the transaction, the chief executive officer now directly owns 48,945 shares in the company, valued at approximately $98,282,049.45. The trade was a 0.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have sold 2,034 shares of company stock valued at $3,778,952 over the last three months. 1.71% of the stock is owned by insiders.

Markel Group Company Profile

(Free Report)

Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.

See Also

Institutional Ownership by Quarter for Markel Group (NYSE:MKL)

Should You Invest $1,000 in Markel Group Right Now?

Before you consider Markel Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Markel Group wasn't on the list.

While Markel Group currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads